The Voxi 5 device provides continuous flow oxygen and is designed for durability and affordability in the US market.
RT’s Three Key Takeaways:
- Stationary Oxygen Expansion: Inogen Inc has introduced the Voxi 5, a stationary oxygen concentrator (SOC) designed to complement its existing line of portable devices for long-term care patients.
- Continuous Flow Delivery: Developed with Yuwell Medical, the device provides 1-5 liters per minute (L/min) of continuous flow oxygen in a compact design featuring caster wheels for easier mobility within the home.
- Market Accessibility: The new concentrator is positioned as a value-driven solution for price-sensitive customers and those requiring additional units for multi-room use, according to the company.
Inogen Inc launched Voxi 5, a new stationary oxygen concentrator (SOC) designed to improve access to oxygen therapy for long-term care patients in the US, according to the company.
The Voxi 5 expands the company’s product portfolio, which currently includes a line of portable oxygen concentrators. Developed in collaboration with Yuwell Medical, the Voxi 5 provides 1-5 LPM of continuous flow oxygen. The company stated the device is designed to be quiet and efficient.
The device features a compact design and includes caster wheels to allow for movement between rooms in a home, providing increased mobility for users, according to the company.
“With Voxi 5, we are fulfilling our mission to make respiratory care more accessible and empowering for patients,” said Inogen president and CEO Kevin Smith. “This launch exemplifies our commitment to innovation, affordability, and enhancing the quality of life for those dependent on oxygen therapy.”
The Voxi 5 is intended to complement the Inogen At Home product by offering a value-driven option for price-sensitive customers or those who need an additional unit for use in multiple rooms. According to the company, the device offers patients and healthcare providers a solution for managing chronic respiratory conditions.
